Results 231 to 240 of about 8,034,760 (273)

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

open access: yesMolecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata   +10 more
wiley   +1 more source

Revealing the Physician's Task Conceptualization in Melanoma Treatment: Qualitative User Experience Study.

open access: yesJMIR Cancer
Hartmann EM   +7 more
europepmc   +1 more source

Reliability of a Novel Qualitative Assessment Tool for Evaluating a Run Plant Task. [PDF]

open access: yesInt J Sports Phys Ther
Butler L   +5 more
europepmc   +1 more source

Sleep, Physical Activity, and Mood Among People Seeking Mental Health Care.

open access: yesJAMA Netw Open
Kulshreshtha A   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy